Business Context and Reporting Period
Company: Philip Morris Companies Inc. (Note: Metadata listed "Altria Group," but the filing text identifies the registrant as Philip Morris Companies Inc., the predecessor to Altria).
Reporting Period: Fiscal year ended December 31, 1993.
Business Overview: The Company is the world's largest consumer packaged goods company, operating primarily through four segments: Tobacco (Philip Morris U.S.A. and International), Food (Kraft General Foods), Beer (Miller Brewing), and Financial Services/Real Estate. Tobacco accounted for 43% of operating revenues and approximately 62% of total operating profit in 1993.
Key Financial Metrics
Revenue and Profit: Specific consolidated revenue and net income figures are not provided in the text; they are incorporated by reference to the Annual Report to Stockholders. However, segment profit contributions are detailed:
- Tobacco: 62% of total operating profit (down from 69% in 1992).
- Food: 33% of total operating profit (up from 27% in 1992).
- Beer: 2% of total operating profit.
- Financial Services/Real Estate: 3% of total operating profit.
Unusual Items and Expenses:
- Restructuring Costs: $741 million provided in 1993 for worldwide operations restructuring.
- Asset Writedowns: $429 million included in restructuring charges ($141M tobacco, $211M food, $77M beer).
- Accounting Changes: $29 million additional operating expense due to adoption of SFAS No. 112.
- Advertising Costs: $2,356 million (down from $2,419 million in 1992).
Debt and Liquidity:
- Short-Term Borrowings (Consumer Products): $268 million aggregate balance at year-end (Bank loans: $276M; Commercial paper: $2,288M; reclassified to long-term: $2,296M).
- Short-Term Borrowings (Financial Services): $932 million aggregate balance at year-end.
- Financial Services Assets: Increased to $5.7 billion (from $5.3 billion in 1992), including $150 million unrealized appreciation on securities.
Material Changes vs. Prior Period
- Tobacco Shipments: U.S. shipments decreased 9.1% to 194.7 billion units (vs. 214.3 billion in 1992). This decline was driven by a strategic price reduction on premium brands (Marlboro) to regain market share, following distributor destocking ahead of a federal tax increase. International Marlboro unit sales increased 3.5% to 240.1 billion units.
- Beer Shipments: Increased 4.3% to 44,024 thousand barrels, driven by the acquisition of Molson Breweries U.S.A. and volume growth in Miller High Life and Miller Genuine Draft.
- Food Segment: Acquired Freia Marabou (Scandinavia), The Terry's Group (UK), and Nabob Foods (Canada). Sold U.S. frozen desserts and frozen vegetables businesses.
- Profit Margins: Tobacco profit margins declined due to the pricing strategy shift, though market share for Marlboro rose from 22.1% to 26.8% by December 1993.
Outlook, Risks, and Contingencies
Management Commentary: Management expects lower profit margins in tobacco to continue until the economic environment improves. The shift from premium to discount segments in the U.S. has reversed in the second half of 1993.
Key Risks and Contingencies:
- Health Litigation: 22 smoking and health actions pending against Philip Morris U.S.A. as of Dec 31, 1993. The Company asserts valid defenses based on federal preemption but notes outcomes are unpredictable.
- Regulatory Actions:
- FDA: Claimed potential authority to regulate cigarettes as drugs due to nicotine addiction; outcome uncertain.
- Taxes: Federal excise tax increased in 1993; a further increase of $0.75 per pack was proposed for 1994.
- Advertising: Bans or restrictions on tobacco advertising in Canada and the European Community.
- Government Investigations: Grand jury investigation regarding the Council for Tobacco Research; DOJ Antitrust Division investigation into joint activity among manufacturers.
- Environmental: 134 proceedings involving potential Superfund liability; expenditures not expected to be material.
Investor Verification Checklist
- Verify the impact of the $741 million restructuring charge on future operating costs and efficiency.
- Monitor the outcome of the FDA's potential regulation of cigarettes as drugs and the status of pending health litigation.
- Assess the sustainability of the tobacco market share gains achieved through price reductions versus the erosion of profit margins.
- Review the consolidated financial statements (incorporated by reference) for total revenue, net income, and cash flow figures not explicitly detailed in this text.
- Track the proposed 1994 federal excise tax increase and its potential impact on volume.